about
Impact of ventilation/perfusion single-photon emission computed tomography on treatment duration of pulmonary embolism.V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism.Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain NetworksPosterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.In vivo retention of 18F-AV-1451 in corticobasal syndrome.Home treatment of patients with small to medium sized acute pulmonary embolism.Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.Perfusion SPECT in patients with suspected pulmonary embolism.Automatic lung segmentation in functional SPECT images using active shape models trained on reference lung shapes from CT.The radiation dose to overweighted patients undergoing myocardial perfusion SPECT can be significantly reduced: validation of a linear weight-adjusted activity administration protocol.Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy.Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.Importance of correct patient positioning in myocardial perfusion SPECT when using a CZT camera.Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera.Ventilation-perfusion SPECT with 99mTc-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease.Left ventricular myocardial perfusion in young patients evaluated for hypertrophic cardiomyopathy at rest and during adenosine hyperemia using cardiac magnetic resonance imaging.Effect of exercise on the plasma vesicular proteome: a methodological study comparing acoustic trapping and centrifugationDiscriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersYoung patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMRVentilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCTTomographic ventilation/perfusion lung scintigraphy in the monitoring of the effect of treatment in pulmonary embolism: serial follow-up over a 6-month periodSubmaximal adenosine-induced coronary hyperaemia with 12 h caffeine abstinence: implications for clinical adenosine perfusion imaging testsDifferences in attenuation pattern in myocardial SPECT between CZT and conventional gamma camerasDiagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterizationThe association between plasma miR-122-5p release pattern at admission and all-cause mortality or shock after out-of-hospital cardiac arrestQualitative assessments of myocardial ischemia by cardiac MRI and coronary stenosis by invasive coronary angiography in relation to quantitative perfusion by positron emission tomography in patients with known or suspected stable coronary artery disHead-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948Comparison of conventional and Si-photomultiplier-based PET systems for image quality and diagnostic performancePredicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's diseaseAppropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decisionIncreased pulmonary blood volume variation in patients with heart failure compared to healthy controls: a noninvasive, quantitative measure of heart failure
P50
Q34790885-75F7C1EB-270E-4FCE-8D8C-39F38A6E72CAQ35781842-422A157F-2EA8-49AB-94B0-FA1A100A54D9Q37731919-40F983F6-98F5-4FBD-9556-D3127D738CE9Q40032113-EAD23FA5-01E3-4861-A3FA-E3ABCA88E9E2Q41591680-95C3F53E-E32F-4BBC-94C4-4D141B0D5640Q43655976-B3B2DA94-68C5-46A5-A6FF-C61F6DD35711Q44132033-4DC4F9AE-8E20-4B9A-A3A1-59DD6E8E3E02Q45247954-F112C571-C6F8-43E6-83CA-E68184256846Q47253583-726A9123-B2E5-446B-A641-B28152EA43DEQ47282568-D9031B26-7482-4213-8D90-21A30F62A128Q47627847-266AF205-81CE-4E4A-9B6D-211F343BBFF2Q47658947-52ED65C9-1CEC-482D-A29E-A6CB2EF4BAF4Q48486327-558A2856-6760-4C0B-81B5-FD2A673CB41EQ50618943-87C894AD-1E1A-42B4-946C-0EDBB3B7203DQ53066806-756C6428-D17E-4D52-84CF-B65AA0138422Q53133296-DBF81817-CE58-4CFF-A61C-35E949124FFFQ53299880-42F57E86-68AF-4FDF-9073-345587572B50Q55540008-8554B7E4-5C7B-4BB4-B556-6BB4193DE38AQ57161388-11FEDE15-8050-4FAA-B321-D42079D5E1D0Q57493164-285A0B9F-EAE8-472A-A070-30A21F6D9B1CQ58471300-B96E7F0B-9826-4E11-A67C-81C803ED880EQ60529215-DA57E21B-C6F1-463F-96CD-0157801C2739Q83610917-93445B86-1DF4-4CF3-972F-5384BF0932B1Q87086561-BADC47B7-B776-4C21-AC98-822557AB537DQ88801740-5BD999FA-0BCA-4D49-BCFF-B5A7D8766089Q90273935-84C7F313-1804-4420-BD3D-277817BB239FQ90275029-1DFDA0EA-347B-432F-8556-29C48F3E592FQ90395563-C198E8D1-01F3-426E-A771-B6F619ACA7E6Q90707233-1D803332-9632-4E94-9A0D-5A0377C8011CQ90879659-B512C787-68FB-4EDA-84A4-FADF10AAD8DEQ91030167-9B4B862C-7FF6-4608-B1D2-27848055F3E0Q91201748-3D7D2F3B-6BD7-4B9B-AB41-074160956F97Q92228728-A2723953-A030-4DBD-BCD5-FE94FD610535
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jonas Jögi
@ast
Jonas Jögi
@en
Jonas Jögi
@es
Jonas Jögi
@nl
Jonas Jögi
@sl
type
label
Jonas Jögi
@ast
Jonas Jögi
@en
Jonas Jögi
@es
Jonas Jögi
@nl
Jonas Jögi
@sl
prefLabel
Jonas Jögi
@ast
Jonas Jögi
@en
Jonas Jögi
@es
Jonas Jögi
@nl
Jonas Jögi
@sl
P106
P21
P31
P496
0000-0002-5299-3628